Bio-Techne (TECH) Invested Capital (2016 - 2023)
Bio-Techne (TECH) posted quarterly Invested Capital of $1.8 million for Q3 2023, down 76.35% year-over-year from $7.4 million in Q3 2022, and down 50.0% quarter-over-quarter from $3.5 million in Q2 2023.
Bio-Techne (TECH) Invested Capital (2016 - 2023) Analysis & Trends
Bio-Techne's Invested Capital history runs 8 years deep, the most recent figure standing at $1.8 million for Q3 2023.
- In Q3 2023, Invested Capital fell 76.35% year-over-year to $1.8 million; the TTM figure through Jun 2024 stood at $1.8 million (down 89.16% YoY), while the FY2023 annual figure was $3.5 million, down 72.0% from the prior year.
- Invested Capital for Q3 2023 stood at $1.8 million, down from $3.5 million in the prior quarter.
- The five-year high for Invested Capital was $12.5 million in Q3 2019, with the low at $1.8 million in Q3 2023.
- The 5-year median for Invested Capital is $5.6 million (2020), against an average of $7.5 million.
- The sharpest annual moves came in 2020 and 2023: Invested Capital surged 267.65% in 2020, then tumbled 76.35% in 2023.
- Bio-Techne's Invested Capital stood at $12.5 million in 2019, then sank by 60.14% to $5.0 million in 2020, then tumbled by 59.86% to $2.0 million in 2021, then surged by 270.0% to $7.4 million in 2022, then sank by 76.35% to $1.8 million in 2023.
- Business Quant data shows TECH's Invested Capital at $1.8 million in Q3 2023, $3.5 million in Q2 2023, and $5.2 million in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 190.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 380.00 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Bio-Techne | 11.33 Bn | 11.12 Bn | 208.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 1.75 Mn |
| Jun 30, 2023 | 3.50 Mn |
| Mar 31, 2023 | 5.25 Mn |
| Sep 30, 2022 | 7.40 Mn |
| Jun 30, 2022 | 12.50 Mn |
| Mar 31, 2022 | 12.50 Mn |
| Dec 31, 2021 | 2.00 Mn |
| Sep 30, 2021 | 5.00 Mn |
| Jun 30, 2021 | 4.00 Mn |
| Mar 31, 2021 | 12.50 Mn |
| Dec 31, 2020 | 4.98 Mn |
| Sep 30, 2020 | 12.50 Mn |
| Jun 30, 2020 | 5.94 Mn |
| Mar 31, 2020 | 12.50 Mn |
| Dec 31, 2019 | 12.50 Mn |
| Sep 30, 2019 | 12.50 Mn |
| Jun 30, 2019 | 3.40 Mn |
| Mar 31, 2019 | 3.40 Mn |
| Dec 31, 2018 | 12.50 Mn |
| Sep 30, 2018 | 12.50 Mn |